Bristol urges combo study with Gilead hepatitis drug

(Reuters) - Bristol-Myers Squibb Co renewed its call for biotechnology company Gilead Sciences Inc to test one of its hepatitis C drugs in late-stage trials alongside Bristol's own promising medicine, following stellar results from a mid-stage...

Source: http://health.yahoo.net/news/s/nm/bristol-urges-combo-study-with-gilead-hepatitis-drug

history Facebook funny UBS AG